Safety analysis of 19 cases of transcatheter aortic valve replacement after COVID-19 infection
Objective:To observe the safety of transcatheter aortic valve replacement (TAVR) for symptomatic aortic valve stenosis patients infected with Corona Virus Disease 2019 (COVID-19) and with negative antigen.Methods:Ninteen patients with symptomatic severe aortic valve stenosis were performed TAVR in 7 hospitals in Shanghai from December 9th, 2022 to January 13th, 2023. The patients were infected with COVID-19 and the antigen turned negative within 15 days. The general conditions, disease history, preoperative examinations, procedures, postoperative examinations, complications and discharge conditions of the patients were summarized and analyzed.Results:Two of the patients were ordinary COVID-19 pneumonia, and the rest were mild. All patients successfully completed the operation, including 1 case of valve-in-valve implantation. Three patients had pacemaker implantation due to complete atrioventricular block, and 1 patient had stroke after operation. There was no mild to moderate or above perivalvular leakage, coronary occlusion or death happened.Conclusion:It is safe for symptomatic aortic valve stenosis patients to perform TAVR within 15 days after antigen negative conversion after infection with mild or common COVID-19 pneumonia.
万方数据
